The startup develops small molecule antibiotic scaffolds that utilize a multi-target strategy to create a pipeline of antibiotics effective against various bacterial pathways. These scaffolds are designed to counteract antibiotic resistance mechanisms, providing healthcare professionals with potent treatment options for resistant infections.
Funding
$13.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The rise of antibiotic-resistant bacteria poses a significant threat to global health, rendering many existing treatments ineffective. Traditional antibiotics often target single bacterial pathways, making them susceptible to resistance mechanisms developed by bacteria. This necessitates the development of new classes of antibiotics that can overcome these resistance mechanisms and effectively combat multi-drug resistant infections.
Solution
X-BiotixRx is developing small molecule antibiotic scaffolds designed to address the growing challenge of antibiotic resistance. Their approach utilizes a multi-target strategy, creating a pipeline of antibiotics that can simultaneously disrupt multiple bacterial pathways. By targeting several essential functions within the bacteria, these scaffolds are designed to be less susceptible to resistance mechanisms. This approach aims to provide healthcare professionals with more effective treatment options for a wide range of resistant bacterial infections.
Target Audience
The primary target audience includes healthcare professionals, hospitals, and pharmaceutical companies seeking new and effective treatment options for resistant bacterial infections.
Features
- Multi-target antibiotic scaffolds designed to inhibit multiple bacterial pathways simultaneously.
- Designed to overcome existing antibiotic resistance mechanisms.
- Development of a pipeline of novel antibiotics.
- Small molecule design for improved drug delivery and bioavailability.